Status:
UNKNOWN
18F-FDOPA PET/CT Imaging in Patients Undergoing Metabolic Surgery
Lead Sponsor:
Korea University Anam Hospital
Collaborating Sponsors:
Myungmoon Pharma. Co. Ltd.
Conditions:
Diabetes Mellitus, Type 2
PreDiabetes
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The aim of the study is to compare the endocrine function of pancreas between pre and post metabolic surgery in patients with type 2 diabetes or prediabetes. The study will examine the endocrine funct...
Eligibility Criteria
Inclusion
- Type 2 diabetes or prediabetes
- Body mass index \>25.0 kg/m2
- Written informed consent
Exclusion
- Diabetes induced by chronic pancreatitis or pancreas cancer
- Chronic glucocorticoid usage
- Significant coronary artery disease or cerebrovascular disease within the previous 3 months
- Uncompensated congestive heart failure
- Severe pulmonary disease defined as FEV1 \< 50% of predicted value
- End stage renal disease on dialysis
- Acute infectious disease within the previous 3 months
- Pulmonary thromboembolism or thrombophlebitis within the previous 3 months
- History of cancer (except for basal cell skin cancer or cancer in situ)
- Prior gastrointestinal surgery (except for appendectomy or hemorrhoidectomy)
- Gastrointestinal disorders, malabsorptive disorders, or inflammatory bowel disease
- History of chronic liver disease (except for NAFLD/NASH)
- Psychiatric disorders including dementia, active psychosis, severe depression requiring \> 2 medications, history of suicide attempts, alcohol or drug abuse within the previous 5 years
Key Trial Info
Start Date :
September 3 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03821961
Start Date
September 3 2018
End Date
December 31 2020
Last Update
February 26 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Korea University Anam Hospital
Seoul, South Korea, 02841